Pilot project for education of patients with type 2 diabetes by pharmacists (original) (raw)
Related papers
Ankara Universitesi Eczacilik Fakultesi Dergisi, 1962
The objective of this study is to adapt and test a community pharmacy educational program for diabetes patients. In the study; The sample consisted of 24 type 2 and 14 type 1 diabetes patients on monotherapy, without severe complications. A patient satisfaction questionnaire (WHO five wellbeing index) was applied in the beginning and at the end of the survey. A five-month education was conducted on common problems and complications of diabetes. The whole program costs were calculated per patient and costeffectiveness ratio was presented. Improvement was observed in patients' diabetes knowledge in both groups, decrease in the frequency of minor hypoglycemic incidents (about 60% less for type 2 and 5% less in type 1diabetes group) and the blood glucose level (statistically significantly in type 2 diabetes patients). The total quality of life according to WHO index increased significantly from 29 to 44% and from 58.57 to 70.28% in diabetes type 2 and 1 patients respectively. The cost-effectiveness ratio calculated on the basis of the intermediate result that is decrease in the blood glucose level per patient is 7.5€ and for type 2 and 42,86 € for type 1 diabetic patients. Introduction of the education program has the potential to decrease the minor diabetes complications and from there-the economic cost of the diabetes as well to improve patient satisfaction and will promote the pharmacies as a source of health education and should be encouraged through the general reimbursement system.
ACTA Pharmaceutica Sciencia, 2020
Type 2 Diabetes is a common incurable metabolic disorder with worldwide increasing prevalence. International Diabetic Association noticed that there is a very fast and alarming increase in the worldwide prevalence of Diabetes. In 2012, diabetic population around the world has reached 371 million people. Untreated or undertreated Type 2 Diabetes does affect the quality of life of the patients both directly by symptoms and indirectly by short term and long-term complications. In addition to the direct effects of type 2 diabetes mellitus, affects the patient's life in a bad way, if the treatment process is not followed carefully, the quality of life of the patient will be reduced. At this point, clinical pharmacist has an extremely important role in determining and executing the correct clinical treatment. Besides that, the importance of the patient's level of knowledge about the disease and its impact on the treatment process is very important. The major goal of this thesis is evaluating the diabetic patients` knowledge on diabetes and the effect of this point on treatment process. This study has been done in Merve Pharmacy of Muğla/Turkey between January and March of 2018. A questionnaire consisting of 20 multiple choice questions has been used to evaluate 50 participants who are clinically diagnosed diabetics. SPSS 23.0 statistical program was used for the statistical analysis of the data and the findings were evaluated at and 5% significance level. It has been statistically observed that knowledge levels of patients affected the treatment process. Recognizing the importance of this factor by clinical pharmacists and other health professionals will increase the training for diabetes and prevent the problems arising from the patient's low-level knowledge.
Immediate impact of a diabetes mellitus education programme on the knowledge of Pharmacists
2013
Background: Diabetes Mellitus is reaching global epidemic proportion which gives an opportunity for pharmacists to demonstrate their impact on patient care. Objectives: This study aims at determining the impact of a Mandatory Continuing Professional Development (MCPD) educational intervention on the knowledge of pharmacists about diabetes. Methods: This was a cross sectional interventional study which utilized the Diabetes Knowledge Test (DKT). It consists of 23 questions that can be self completed in 15minutes. Pharmacists who registered for the MCPD programme and who consented to participate in the study were each given 2 copies of the questionnaire. The first was completed at baseline and the other after the educational intervention. Results: Overall, 83 pharmacists were included in the study and these were those who completed the pre and post education intervention questionnaires. The average age of the respondents was 45.7 years. There was a statistically significant increase i...
Current Research in Diabetes & Obesity Journal, 2016
Background: Diabetes mellitus is a chronic metabolic disorder that presents high morbidity and mortality with significant reduction in patient's quality of life. The present study was conducted to evaluate the effect of pharmacist led educational interventions on disease knowledge and glycaemic control in patients with diabetes mellitus. Methodology: A prospective randomized educational interventional study was carried out in the General Medicine Outpatient department in a South Indian teaching hospital, Mangalore, Dakshina Kannada district for a period of 12 months from October 2014-September 2015. Results: A total of 106 patients who met the study criteria were enrolled and randomly divided into usual care and intervention groups. Data were collected by using a validated questionnaire developed by the researcher for overall diabetes knowledge to both the groups at the beginning and at the end of the study. The results showed a significant increase in overall diabetes knowledge from 18.05 to 25.43 (p <0.001) in the intervention group as compared to usual care group (19.78-18.07, p =0.007). The mean scores of patient's knowledge about diabetes, self-care practices and knowledge regarding complications of diabetes mellitus with respect to all the domains in the intervention group showed a significant improvement (p<0.05).A significant decrease (p<0.001) in the fasting and post prandial blood glucose levels was observed in the final follow up from the baseline period in the intervention group. Conclusion: The study highlights the positive impact of clinical pharmacist led intervention through education programme on improving disease knowledge and clinical outcomes in patient with diabetes mellitus.
2015
Diabetes mellitus, it is a very dangerous non communicable disease which results in the death of millions usually in the developed countries. Diabetes mellitus along with the co-morbidities has been reported as the fifth leading cause of death, and the studies show that most often the developed countries where the people are less bothered about their food habits are most affected. There are 3 main types of diabetes: Type I, Type II, and Gestational diabetes mellitus. Type II is the most common form of diabetes and accounts for 90 to 95% of Diabetes cases. Chronic hyperglycemia without proper management can also lead to various short term and long term secondary complications, both of small and big, vascular nature which may be determined as the main cause of mortality and morbidity in type 2 diabetic patients all over the world. The study conducted strictly observed the diabetes affected people in a particular area and the co-morbidities were studied in a very detailed and elaborate...
Effectiveness of Pharmacist-Administered Diabetes Mellitus Education and Management Services
Pharmacotherapy, 2005
To evaluate the effectiveness of pharmacist-administered diabetes mellitus education and management services on selected diabetes performance measures. Additional goals were to compare outcomes with goals specified for patients with diabetes by the National Committee for Quality Assurance (NCQA) and identify areas for improvement. Design. One-year observational study. Setting. Three university-based primary care clinics. Patients. One hundred ninety-one patients with diabetes. Intervention. Pharmacist-provided diabetes education and management services.
International Journal of Pharmacy and Pharmaceutical Sciences, 2021
Objective: The purpose of the study was to analyze the effect of clinical pharmacist intervention on glycemic control based on fasting blood glucose and glycosylated blood glucose level. Methods: A randomized prospective interventional study was conducted in the outpatient department of a tertiary care hospital. Patients suffering from diabetes for a least 2 y were selected for the study based on the inclusion and exclusion criteria. The control group was not given any special pharmacist care, while the interventional group had a face-to-face interview, counseling, and telephonic follow-up during the study period. Based on the baseline values and endpoint parametric values, the result of the study was analyzed. Results: The study was analyzed based on the difference in the glycemic index, using HbA1c and FBS values. The basal values of HbA1c were similar for both groups (8.5%), but a marked reduction to 7.2% was observed in the interventional group. FBS values reduced from 208 mg/dl to 186 mg/dl in the intervention group, while in the usual care group, the reduction was from 211 mg/dl to 198 mg/dl. Conclusion: The inclusion of clinical pharmacists in the healthcare team can offer a remarkable improvement in patient's condition by providing more support in the therapy.
International Journal of Pharmacy and Pharmaceutical Sciences, 2017
Objective: The study aims to determine the influence of education of drug information by the pharmacist on the improvement of knowledge and therapeutic target to type 2 diabetes mellitus outpatients in Dr. Moewardi Surakarta Hospital. Methods: The research used the quasi-experimental method, repeated measure experiment design, pre-posttest design with the prospective patient data retrieval. 90 patients with type 2 diabetes mellitus were used as the subjects of the research divided into three groups (two test groups and one control group). In the test1 group, patients were educated about the drug information through leaflets and through oral explanation, the test 2 group through leaflets, and a control group through leaflets once at the beginning of the study. The study lasted for three months in which in every month fasting blood glucose levels (FBG) and blood glucose levels were analyzed within two hours after a meal (BG2PP) and given questionnaires knowledge to see the socio-demographic profile, knowledge, and blood glucose level of the patient. The data analysis used the statistical package for social sciences (SPSS) version 16 in the form of analysis Kolmogorov-Smirnov test and one-way anova test. Results: The results showed that the education of the drug information by a pharmacist using leaflets and oral explanation in the test1 group was able to improve knowledge of type 2 diabetes mellitus outpatients in Dr. Moewardi Surakarta Hospital, in comparison to the leaflets giving information only to the test 2 group and control group. The education of drug information on the test 1 group was able to improve the patients' knowledge reaching 100%. Type 2 diabetes outpatients in the test 1 group could achieve a reduction in blood sugar levels, to the FBG level (136.47±36.08) mg/dl and BG2PP levels (193.43±58.21) mg/dl. Conclusion: The education of drug information from the pharmacist had the influence to improves the knowledge and therapeutic target of type 2 diabetes mellitus outpatients in Dr. Moewardi Surakarta Hospital.
Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2011
This study was conducted to evaluate the effect of a clinical pharmacist-led patient education program for type 2 diabetic patients at Isfahan Endocrine & Metabolism Research Center (IEMRC) from April 2008 to January 2009. In a randomized controlled clinical trial, a total of 172 patients with uncontrolled type 2 diabetes were selected and randomly allocated into control and intervention groups. After taking informed written consent, the intervention group received an educational program about oral anti-hyperglycemic medications, adherence, diabetes dairy log and pill box usage. Patient's glycemic control in the intervention group was followed for three months through either telephone or face to face interviews with the pharmacist. Fasting blood glucose and HbA1c were measured at the start and end of the pharmacistled drug education program for both intervention and control groups. After a three months follow-up, mean fasting blood glucose and HbA1c of the patients in the interv...
Integrated Pharmacy Research and Practice, 2017
Type 2 diabetes is a chronic disease occurring in ever increasing numbers worldwide. It contributes significantly to the cost of health globally; however, its management remains in the most part less than optimal. Patients must be empowered to self-manage their disease, and they do this in partnership with health care professionals. Whilst the traditional role of the pharmacist has been centered around the supply of medicines and patient counseling, there is an evergrowing body of evidence that pharmacists, through a range of extended services, may contribute positively to the clinical and humanistic outcomes of those with diabetes. Further, these services can be delivered cost-effectively. This paper provides a review of the current evidence supporting the role of pharmacists in diabetes care, whilst providing a commentary of the future roles of pharmacists in this area.